🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⁦Dusten Unruh⁩ presenting his work on venous thromboembolism risk prediction in #glioma patients. #SNO2019 ⁦SNO⁩

Amorphous thoughts to written words, I'm honored to share my first piece in major news outlet Chicago Tribune on #bias and #disability. Grateful for instruction from The OpEd Project thanks to support by @TGSatN and lessons in advocacy Northwestern Feinberg School of Medicine chicagotribune.com/opinion/letter…

Great to hear Daniel Brat, MD, PhD present the latest updates on glioma classification #SNO2021

This reports an unusual case where a low-grade #glioma only had IDHmut and did not recur or cause breakthrough seizures until 22 years after diagnosis, without a progression in grade. Yet, seizures manifested at both original presentation and recurrence. buff.ly/37YFdJR

Very grateful to the American Association of Neuropathologists for this award. Looks good on my office wall! ⁦AANP⁩ #aanp2022 #neuropath2022 #neuropath

Proud to share this review written with Marc Schubert about brain tumor networks as a contribution to #CancerNeuroscience. Thank you so much Varun Venkataramani for the supervision and Wolfgang Wick 🇪🇺, T. Kuner, @Winkler_Lab for contributions!

This was a MASSIVE undertaking, took seven years of research and was delayed by the #COVID19 pandemic. But we finally saw it through to completion. And to think, it all started ~12 years ago, when I noticed that IDHmut gliomas never seemed to contain microthrombi...

Really glad to announce our newest paper on treating seizures in IDH mutant glioma patients is published in Journal of Clinical Investigation! pubmed.ncbi.nlm.nih.gov/37104042/